D-1390-2012 Class III Terminated
FDA drug recall D-1390-2012 was initiated by Hospira, Inc. on Apr 5, 2012 and is designated Class III. Reason for recall: Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate. The recall status is terminated (terminated Aug 8, 2013). Affected quantity: 164,568 containers.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 27, 2012
- Initiation Date
- Apr 5, 2012
- Termination Date
- Aug 8, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 164,568 containers
Product Description
Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.
Reason for Recall
Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
Distribution Pattern
Nationwide
Code Information
Lot #: 04510KL*, Exp 01OCT2012; *lot number may have 01 or 02 following it
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1390-2012
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026